News

The investment program will be completed before the end of 2011. The centers will enforce sustainable development in the region and give a boost to Solvay’s presence in

Steve Turner, CEO of Protea, said: “We are pleased to have our technology recognised by the US patent office. Patents are the key assets of biotechnology, as they

Initial results suggest that the diagnostic accuracy of this new test will be greater than 97% for early stage ovarian cancer. The advice has come from the company’s

The patented nanoparticle technology solubilises pharmaceutical compounds in fatty acids and/or fatty alcohols. The formulation achieves aqueous form after dilution with equimolar of protonating agent, thereby keeping the

Ofirmev is Cadence’s proprietary intravenous formulation of Acetaminophen. Acetaminophen has been used as a medication for the treatment of pain and fever in the US, and is available

Andrew Berlin, chairman and CEO of Berlin Packaging, said: “This exciting transaction unites two highly complementary businesses and will enable us to continue to unlock value for our

Zanamivir is marketed globally by GlaxoSmithKline (GSK) under the trade name, Relenza. Zanamivir is one of only two WHO approved drugs to which the new H1N1 strain of

The launch represents the commercialisation of a blood-based test for the detection of cancer in companion animals. The test detects the presence of Recaf, a universal marker for

Prior to taking the helm at Unilever, Polman was a top executive of both Procter & Gamble and Nestle. Polman was chief financial officer and executive vice president